1. Home
  2. CLAR vs GLSI Comparison

CLAR vs GLSI Comparison

Compare CLAR & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLAR
  • GLSI
  • Stock Information
  • Founded
  • CLAR 1957
  • GLSI 2006
  • Country
  • CLAR United States
  • GLSI United States
  • Employees
  • CLAR N/A
  • GLSI N/A
  • Industry
  • CLAR Recreational Games/Products/Toys
  • GLSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLAR Consumer Discretionary
  • GLSI Health Care
  • Exchange
  • CLAR Nasdaq
  • GLSI Nasdaq
  • Market Cap
  • CLAR 173.0M
  • GLSI 159.8M
  • IPO Year
  • CLAR N/A
  • GLSI 2020
  • Fundamental
  • Price
  • CLAR $4.79
  • GLSI $12.69
  • Analyst Decision
  • CLAR Strong Buy
  • GLSI Strong Buy
  • Analyst Count
  • CLAR 3
  • GLSI 1
  • Target Price
  • CLAR $6.33
  • GLSI $38.00
  • AVG Volume (30 Days)
  • CLAR 129.0K
  • GLSI 41.9K
  • Earning Date
  • CLAR 03-06-2025
  • GLSI 11-14-2024
  • Dividend Yield
  • CLAR 2.13%
  • GLSI N/A
  • EPS Growth
  • CLAR N/A
  • GLSI N/A
  • EPS
  • CLAR 0.13
  • GLSI N/A
  • Revenue
  • CLAR $269,413,000.00
  • GLSI N/A
  • Revenue This Year
  • CLAR N/A
  • GLSI N/A
  • Revenue Next Year
  • CLAR $9.30
  • GLSI N/A
  • P/E Ratio
  • CLAR $37.10
  • GLSI N/A
  • Revenue Growth
  • CLAR 48.98
  • GLSI N/A
  • 52 Week Low
  • CLAR $3.89
  • GLSI $8.15
  • 52 Week High
  • CLAR $7.55
  • GLSI $21.44
  • Technical
  • Relative Strength Index (RSI)
  • CLAR 46.08
  • GLSI 51.69
  • Support Level
  • CLAR $4.66
  • GLSI $12.71
  • Resistance Level
  • CLAR $5.08
  • GLSI $13.60
  • Average True Range (ATR)
  • CLAR 0.17
  • GLSI 0.70
  • MACD
  • CLAR 0.01
  • GLSI 0.06
  • Stochastic Oscillator
  • CLAR 30.56
  • GLSI 42.80

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a global leader in designing, manufacturing, and marketing innovative outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of highly-engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. Its Product Candidates include; GP2, a HER2/neu transmembrane peptide that elicits a targeted immune response against HER2/neu-expressing cancers, GM-CSF Immunoadjuvant has been shown to enhance monocyte and neutrophil cytotoxicity against melanoma tumor cells and to enhance activity-dependent cellular cytotoxicity of monocytes and neutrophils against targets coated with the anti-ganglioside antibodies, and Cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells to inhibit the spread of cancer.

Share on Social Networks: